Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA 98109, USA; Center for Cardiovascular Biology, University of Washington, Seattle, WA 98109, USA; Department of Medicine/Cardiology, University of Washington, Seattle, WA 98109, USA.
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
J Mol Cell Cardiol. 2023 Jun;179:60-71. doi: 10.1016/j.yjmcc.2023.03.017. Epub 2023 Apr 3.
Standard transgenic cell line generation requires screening 100-1000s of colonies to isolate correctly edited cells. We describe CRISPRa On-Target Editing Retrieval (CRaTER) which enriches for cells with on-target knock-in of a cDNA-fluorescent reporter transgene by transient activation of the targeted locus followed by flow sorting to recover edited cells. We show CRaTER recovers rare cells with heterozygous, biallelic-editing of the transcriptionally-inactive MYH7 locus in human induced pluripotent stem cells (hiPSCs), enriching on average 25-fold compared to standard antibiotic selection. We leveraged CRaTER to enrich for heterozygous knock-in of a library of variants in MYH7, a gene in which missense mutations cause cardiomyopathies, and recovered hiPSCs with 113 different variants. We differentiated these hiPSCs to cardiomyocytes and show MHC-β fusion proteins can localize as expected. Additionally, single-cell contractility analyses revealed cardiomyocytes with a pathogenic, hypertrophic cardiomyopathy-associated MYH7 variant exhibit salient HCM physiology relative to isogenic controls. Thus, CRaTER substantially reduces screening required for isolation of gene-edited cells, enabling generation of functional transgenic cell lines at unprecedented scale.
标准的转基因细胞系生成需要筛选 100-1000 个菌落以分离正确编辑的细胞。我们描述了 CRISPRa On-Target Editing Retrieval(CRaTER),它通过靶向基因座的瞬时激活来富集具有 cDNA-荧光报告基因的靶向敲入的细胞,然后通过流式分选来回收编辑的细胞。我们表明,CRaTER 从人诱导多能干细胞(hiPSC)中转录失活的 MYH7 基因座的杂合子、双等位基因编辑的稀有细胞中回收,与标准抗生素选择相比,平均富集 25 倍。我们利用 CRaTER 富集 MYH7 基因中的变体文库的杂合敲入,该基因中的错义突变导致心肌病,并且回收了具有 113 种不同变体的 hiPSC。我们将这些 hiPSC 分化为心肌细胞,并表明 MHC-β 融合蛋白可以按预期定位。此外,单细胞收缩性分析显示,与同基因对照相比,具有致病性、肥厚型心肌病相关 MYH7 变体的心肌细胞表现出显著的 HCM 生理学特征。因此,CRaTER 大大减少了分离基因编辑细胞所需的筛选,从而能够以前所未有的规模生成功能性转基因细胞系。